RTN4 and multiple sclerosis: Increased levels of Nogo-A have been reported in schizophrenia (Novak et al., 2002), multiple sclerosis (Satoh et al., 2005), temporal lobe epilepsy (Bandtlow et al., 2004) and Alzheimer’s disease (Gil et al., 2006).